Navigation Links
There's No Place Like the Bathroom During the Holidays
Date:12/4/2008

CLEVELAND, Dec. 4 /PRNewswire/ -- Of the estimated 25 to 45 million Americans who have irritable bowel syndrome (IBS), a significant number avoid seeing their families, attending parties and even shopping during the holiday season because of their digestive disorder. Running to the bathroom and unpredictable digestive symptoms often make road trips difficult, socializing embarrassing and enjoying popular holiday meals nearly impossible.

For the approximately one in five Americans suffering from IBS, an often debilitating digestive disorder associated with a number of painful and embarrassing symptoms, the holidays can be anything but festive due to added stress and social pressures, and that is in addition to the average 22 days of work they miss each year due to their IBS. A recent Zoomerang survey of 382 IBS sufferers revealed that the holiday season is particularly difficult for this group. According to the survey, conducted for Ganeden Biotech Inc., the largest seller of over-the-counter probiotics products in the U.S.:

    -- Thirty percent or more of respondents avoid travel, shopping,
       entertaining and holiday parties because of their IBS-related symptoms
    -- Two-thirds of respondents experience added stress during the holidays,
       a main factor in exacerbating IBS symptoms like bloating, gas, diarrhea
       and constipation
    -- Many respondents reported avoiding popular holiday foods because of
       their IBS, with 46 percent avoiding eggnog, 22 percent avoiding gravy,
       12 percent avoiding stuffing and 10 percent avoiding apple pie
    -- Eighty-one percent of respondents would have a more enjoyable holiday
       experience if their IBS symptoms were effectively managed

"The holidays are a stressful time, often made more stressful for the millions of people with IBS due to uncomfortable, and many times debilitating, digestive symptoms that can lead to not atte
'/>"/>

SOURCE Ganeden Biotech
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Allied National Partners With Healthplace America to Provide Significant Healthcare Savings
2. Resurrection Health Care Named One of Nations Best Places to Work in Healthcare
3. Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
4. Health study in northern Uganda calls for improved services for internally displaced persons
5. Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013
6. Healthplace America Delivers the First and Only Surgery Benefit Management Solution Through the Healthplace Benefit(TM)
7. Environmental Tectonics Corporations BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers
8. Great California Workplace Award Goes to Company Facing Lawsuits, Possible Federal Complaint
9. OneMedPlace announces "OneMedForum 2009" finance conference for emerging medtech companies : Second annual event to be held January 13-14, 2009, in San Francisco
10. A Place for Mom Hires Former VP of Sales and Marketing of Assisted Living Concepts as Market Development Coach
11. What happens in Vegas? Place as a risk factor for suicide
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 1AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 1PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 2
Other Medicine Technology:Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10